Humana Inc. $HUM Shares Bought by NEOS Investment Management LLC

NEOS Investment Management LLC lifted its stake in shares of Humana Inc. (NYSE:HUM) by 10.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,136 shares of the insurance provider’s stock after acquiring an additional 1,842 shares during the period. NEOS Investment Management LLC’s holdings in Humana were worth $7,601,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Retireful LLC acquired a new position in Humana during the second quarter worth approximately $1,250,000. Braidwell LP acquired a new position in shares of Humana in the 2nd quarter valued at $45,482,000. Continuum Advisory LLC purchased a new stake in shares of Humana during the 2nd quarter valued at $93,000. Nykredit A S purchased a new stake in shares of Humana during the 2nd quarter valued at $13,705,000. Finally, B. Metzler seel. Sohn & Co. AG increased its holdings in shares of Humana by 51.8% during the 2nd quarter. B. Metzler seel. Sohn & Co. AG now owns 8,029 shares of the insurance provider’s stock worth $3,189,000 after buying an additional 2,741 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Down 1.4%

Shares of NYSE HUM opened at $400.70 on Friday. The stock has a fifty day moving average price of $388.44 and a 200 day moving average price of $296.00. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a market cap of $48.12 billion, a P/E ratio of 37.91, a P/E/G ratio of 2.63 and a beta of 0.74.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the prior year, the business earned $6.27 earnings per share. The company’s revenue was up 26.2% compared to the same quarter last year. Research analysts anticipate that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana’s dividend payout ratio (DPR) is 33.49%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on HUM. Leerink Partners upgraded Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price on the stock in a report on Thursday, July 30th. Weiss Ratings upgraded Humana from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, August 14th. Zacks Research lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Lake Street Capital started coverage on Humana in a report on Thursday, July 30th. They set a “buy” rating for the company. Finally, JPMorgan Chase & Co. increased their target price on shares of Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research report on Monday, August 10th. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $403.91.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.